Posts Tagged ‘Alzheimer’s disease’
Diabetes and Alzheimer’s appeal against the relationship between doctors and labs
The Association for Independent Medical Education to serve only health professionals and patients (Formindep) filed Monday, December 7, two appeals before the Council of State seeking the annulment of two “recommendations for good medical practice” of Haute Autorité de Santé (HAS). These recommendations focus on the treatment of type 2 diabetes and Alzheimer’s disease.
The association said that “contrary to law and rules of the HAS, many experts involved in developing these recommendations have not declared their ties with the interests of pharmaceutical companies. Other experts are so important links with the pharmaceutical companies that their participation in working groups of these recommendations should have been allowed, in particular the chairmen of these groups. ” In both cases, “Either these statements have not been made, or they have not been published,” said Mr. Bernard Fau, lawyer Formindep.
He is Professor Serge Halimi, Head of Endocrinology Diabetology Nutrition CHU de Grenoble, head of the Expert Group of the HAS recommendations on the type 2 diabetes, in 2006, when referred by the Appeal of Formindep, and Professor Florence Pasquier, a neurologist at University Hospital of Lille, who was the head of the group of experts on Alzheimer’s disease in 2008.
The HAS develop recommendations for best practices that “describe the most appropriate care to patients, given the current state of knowledge and medical practices. They “needed to doctors because they are normative and often gospel truth,” said Dr. Philip Foucras, president of Formindep. They serve as reference for the primary and continuing training of physicians, and Social Security (contracts, medical references …)